We are reviewing a request to add Exparel to formulary at our pediatric hospital. There are 2 main concerns we have with this medication: 1. Cannot administer a local anesthetic for 96 hrs after Exparel administration due to toxicity, 2. Looks like propofol but cannot be given IV so concern for wrong route error and harm.
If your institution has Exparel on formulary, what mitigations do you have in place to prevent these errors from reaching the patient?
Thank you in advance!